EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Biological validation of peak‐width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium

Alison M Luckey iD, Saptaparni Ghosh, Chen-Pin Wang, Alexa Beiser, Rebecca Bernal, Zhiguang Li, Djass Mbangdadji, Elyas Fadaee, Haykel Snoussi, Angel Gabriel Velarde Dediós, Hector A Trevino, Monica Goss und 28 weitere

Alzheimer's & Dementia · 2024-12 · 20 (12) · 8814-8824

DOI: 10.1002/alz.14345 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 21.11.2024. Verfasst von Alison M Luckey und 39 weiteren Autor:innen. Beteiligte Einrichtung: Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Diffusion Tensor Imaging, Biomarkers, Cognitive Dysfunction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke (NINDS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Peak‐width of skeletonized mean diffusivity (PSMD), a neuroimaging marker of cerebral small vessel disease (SVD), has shown excellent instrumental properties. Here, we extend our work to perform a biological validation of PSMD. METHODS We included 396 participants from the Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia (MarkVCID‐1) Consortium and three replication samples (Cohorts for Heart and Aging Research in Genomic Epidemiology = 6172, Rush University Medical Center = 287, University of California Davis Alzheimer's Disease Research Center = 567). PSMD was derived from diffusion tensor imaging using an automated algorithm. We related PSMD to a composite measure of general cognitive function using linear regression models adjusting for confounders. RESULTS Higher PSMD was associated with lower general cognition in MarkVCID‐1 independent of age, sex, education, and intracranial volume (Beta [95% confidence interval], −0.8 [−1.2, −0.4], P < 0.001). These findings were replicated in independent samples. Furthermore, PSMD explained cognitive status above and beyond white matter hyperintensities. DISCUSSION Our biological validation work supports the pursuit of larger clinical validation studies evaluating PSMD as a susceptibility/risk biomarker of small vessel disease contributing to cognitive impairment and dementia. Highlights Peak‐width of skeletonized mean diffusivity (PSMD) is a novel small vessel disease neuroimaging biomarker. A prior instrumental validation study demonstrated that PSMD is a robust biomarker. This biological validation study shows that high PSMD relates to worse cognition. PSMD explains cognitive function above and beyond white matter hyperintensities. Future clinical validation will assess PSMD as a vascular contribution to cognitive impairment and dementia biomarker in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diffusion Tensor ImagingBiomarkersCognitive DysfunctionHumansFemaleMaleAgedCerebral Small Vessel DiseasesDementia, VascularMiddle AgedBrainNeuroimagingAged, 80 and over

Stichwörter der Autor:innen

biomarkercognitive impairmentdiffusion tensor imagingpeak‐width of skeletonized mean diffusivitysmall vessel diseasevascular contributions to cognitive impairment and dementia

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Department of Neurology, Boston Chobanian & Avedisian University School of Medicine, Boston, Massachusetts, USA.
  • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Intramural Research Program, Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Gaithersburg, Maryland, USA.
  • Department of Radiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
  • Center for Memory and Aging, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.

ORCID-Profile: Alison M Luckey

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • NCATS NIH HHS

Zitieren

APA

Luckey, A. M., Ghosh, S., Wang, C. P., Beiser, A., Bernal, R., Li, Z., Mbangdadji, D., Fadaee, E., Snoussi, H., Dediós, A. G. V., Trevino, H. A., Goss, M., Hillmer, L. J., Bauer, C. E., Staffaroni, A. M., Stables, L., Albert, M., Himali, J. J., Mosley, T. H., …, & Satizabal, C. L. (2024). Biological validation of peak‐width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium. Alzheimer's & Dementia, 20(12), 8814-8824. https://doi.org/10.1002/alz.14345

Vancouver

Luckey AM, Ghosh S, Wang CP, Beiser A, Bernal R, Li Z, et al. Biological validation of peak‐width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium. Alzheimer's & Dementia. 2024;20(12):8814-8824. doi:10.1002/alz.14345

BibTeX
@article{Luckey2024,
  author = {Luckey, Alison M and Ghosh, Saptaparni and Wang, Chen-Pin and Beiser, Alexa and Bernal, Rebecca and Li, Zhiguang and Mbangdadji, Djass and Fadaee, Elyas and Snoussi, Haykel and Dediós, Angel Gabriel Velarde and Trevino, Hector A and Goss, Monica and Hillmer, Laura J and Bauer, Christopher E and Staffaroni, Adam M and Stables, Lara and Albert, Marilyn and Himali, Jayandra J and Mosley, Thomas H and Forsberg, Lars and Guðnason, Vilmundur and Singh, Baljeet and Singh, Herpreet and Schwab, Kristin and Kramer, Joel H and Rosenberg, Gary A and Helmer, Karl G and Greenberg, Steven M and Habes, Mohamad and Wang, Danny J J and Gold, Brian T and Lu, Hanzhang and Caprihan, Arvind and Fornage, Myriam and Launer, Lenore J and Arfanakis, Konstantinos and Seshadri, Sudha and DeCarli, Charles and Maillard, Pauline and Satizabal, Claudia L},
  title = {Biological validation of peak‐width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {12},
  pages = {8814--8824},
  doi = {10.1002/alz.14345}
}
Kostenlos starten →